SHARELIFE BOARD
The ShareLife Board comprises professionals from a range of disciplines including healthcare, business, communications, marketing, innovation, project management, accounting and law as well organ donation recipients. Together, they work to build effective partnerships to implement organ donation leading practice in Australia.
Marvin Weinman (Chairman and Co-founder) is a company director and business advisor with over 20 years’ experience in managing companies in Australia, New Zealand, United States, Asia, Japan and Canada. Marvin has a wide-ranging management background in marketing, supply chain management and financial and strategic planning within the fast moving consumer goods, apparel products and the building material industries.
With a track record of driving major change and improvement programs, his executive experience includes MD of George Weston Foods – with a turnover of over $1.6 billion – owners of some of Australian’s most iconic food brands such as Tip Top bread and Wagon Wheels. He was Managing Director of Boral Building products with sales in excess of $1.2 billion and he served as general manager for Laminex Industries and Formica Asia.
Marvin is currently a director for ProPlanet, T-BoxCanada, CoSports Australia and Walden Farms International. He holds economics and sociology qualifications and was a member of the Business Council of Australia and the Australian Institute of Company Directors and a Trustee of the Committee for Economic Development of Australia.
Since semi-retiring Marvin has developed a strong community interest. As a former Director for the Garvan Research Foundation, he is now enjoying imparting his business knowledge into non-profit community interests.
Marvin has been married to wife Linda for over 30 years and is a proud father of two sons, and grandfather to Charlie.
Gary Allen
Gary has worked in the human research ethics area since 1997, working with a number of research institutions, state and federal departments, private companies and research ethics committees in Australia, Canada, the United Kingdom and Vietnam. He has a degree in education and a professional doctorate in social sciences. His doctoral thesis on the establishment of positive institutional research ethics arrangements was recognised with an Outstanding Doctoral Thesis Award from the Queensland University of Technology. Gary has a fulltime and ongoing position as a Senior Policy Officer at the Office for Research, Griffith University, Queensland, Australia.
His knowledge and expertise in regards to the national and international governance of ethical conduct in research has resulted in him serving on numerous national committees, on four separate occasions as a training facilitator for the NHMRC and to advise the committee working on the 2007 review of the National Statement with regards to the conduct of proportional review. Gary is a current member of the Australian Health Ethics Committee and is serving on a number of NHMRC working groups.
Gary Buck is a successful author and global CIO.
Gary was the former CIO of BHP Billiton – Iron Ore, Aluminium, Diamonds and IT Businesses Gary’s CIO appointments in the mining industry saw him with responsibilities in locations such as Mozambique, South Africa, Suriname, Canada, Democratic Republic of Congo, Guinea, England and Australia – he has lead large teams across the globe. Gary was also the CIO of CPA Australia and then worked on the IT supplier side with Wipro. In recent times he has provided high level business / technology advice to the Heart Foundation and National Aboriginal Community Controlled Health (NACCHO).
Barry Catchlove
Dr Barry Catchlove AM graduated from Sydney Medical School in 1966. When he started the program at the age of 16, his cohort of 800 was the largest of its size since the influx of students following the Second World War. At the time, the University of Sydney was the only medical school in New South Wales.
After completing his medical studies and training as a physician at Royal Prince Alfred Hospital, Dr Catchlove pursued an impressive career in healthcare management spanning five decades. He took on a number of varied roles in operations and management, leading reform in public and private hospitals across Australia.
Jerome Goldberg
Jerome Goldberg graduated with a M.B. B.S. from Sydney University in 1981 and completed his orthopaedic training on the Sydney Orthopaedic Scheme in 1988 gaining his F.R.A.C.S and F.A.Orth.A. He completed a post graduate Orthopaedic Fellowship at the New York Orthopaedic Hospital – Columbia Presbyterian Medical Center on the Shoulder and Elbow Service.
For many years Dr Goldberg was a visiting medical officer at the Prince of Wales Hospital and Prince of Wales private hospital. He has numerous publications in literature and specialises in conditions of the shoulder, with an interest in arthroscopic shoulder surgery and shoulder instabilities.
Jerome Goldberg is a past president of the Shoulder and Elbow Society of Australia and is presently a board member of the International Board of Shoulder and Elbow Surgery. He has an interest in research related to shoulder surgery and bone/tissue banking working closely with the Prince of Wales Orthopaedic Research Laboratory.
He is a founding member and current chairman of Australian Biotechnologies, and a member of the Australian Tissue Banking Association.
William (Gus) McIvor is an Executive Director of BG Capital Corporation Limited.
Gus has over 29 years of experience working in property markets, funds management and business development. Gus has held numerous senior positions including co-founder and Director of Sakkara, Executive Director and CEO of Mirvac Funds and BZW Mirvac Funds Limited respectively as well as Head of Bankers Trust Property Advisory team.
Gus is a transplant recipient.
Professor Geoffrey McCaughan
Professor McCaughan graduated in Medicine from the University of Sydney with Hons 1 in 1975. He obtained his FRACP in 1980 specialising in Gastroenterology and Liver diseases. He completed a PHD and was a C.J.Martin NHMRC fellow at the Sir William Dunn School of Pathology, Oxford University from 1984-1986. During this time, he cloned the Human CD200 gene.
Professor McCaughan returned to Australia in 1986 to take up a position as Staff Specialist in Hepatology and Director of Liver Transplant Hepatology at the Australian National Liver Transplant Unit at Royal Prince Alfred.
He was appointed as Associate Professor of Medicine at the University of Sydney in 1992 and as Professor of Medicine and Director at University of Sydney and Royal Prince Alfred Hospital in 1998. He has been Director of The Australian Liver Transplant Unit at RPAH and the University of Sydney from 2001-2003 and from 2004-present. He has been Group Head of the Liver Immunobiology Laboratory at the Centenary Research Institute for Cancer and Cell biology since 1996 and was appointed Assistant Director of the Institute in 2008.
He has an international profile via the publication of over 300 papers in the International literature and over 90 International invitations to speak at recognised International meetings.
Katie Malyon B.A. (Qld), LL.B (Hons) (Sydney), GAICD has nearly 30 years experience in law. Currently a part-time Member of the Migration Review Tribunal – Refugee Review Tribunal, Katie was formerly an Executive Director with Ernst & Young.
This follows successful establishment of her own multi-award winning law firm that was recognised in the BRW’s Fast 100 in 2010. Katie was a finalist in the Telstra Business Women’s Award NSW in 2012.
After initially working as a teacher in Brisbane and Jakarta, Katie commenced her legal career with Clayton Utz and was a Partner with Australian Business Lawyers. She was recognised by her peers and named by the Australian Financial Review as one of the Best Lawyers – Immigration 2010 – 2014.
In early 2014, Katie was appointed to the Federal Government’s panel set up to review the sponsored employee 457 visa program. Amongst her other board activities involving community work, Katie was for 6 years a Director of the Migration Institute of Australia Limited. She is regularly invited to give presentations to the legal profession (both locally and abroad) on strategy and practice management issues.
Brian Myerson (Co-founder) The inspiration behind ShareLife, Brian is a kidney and pancreas transplant recipient from a deceased donor whose wonderful family had made the kind and generous decision to donate his organs.
After 35 years of diabetes he succumbed to diabetic nephropathy and commenced dialysis. His experiences during dialysis, with people dying and others becoming depressed due to a shortage of donated organs, led him to dedicate his efforts to saving many more lives of those suffering from organ failure.
While searching for a solution to Australia’s extremely low organ donation rate (10.5 dpmp in 2002) it was suggested he meet with Marvin Weinman. The meeting on 8 April 2003 profoundly affected both their lives as they set about finding ways to establish Australia as a leader in organ donation for transplantation.
As an MBA graduate, Brian has worked for Standard Bank of South Africa, Bank of Montreal in Canada and Hill Samuel Australia, and then directed family companies in construction and development.
Holly Northam is Assistant Professor in Critical Care Nursing at the University of Canberra, teaching at both postgraduate and undergraduate levels. She is a Registered Nurse and Midwife with many years of experience in critical care environments, and is currently a doctoral scholar investigating “The factors that influence families who decline organ donation”.
Holly is a visiting scholar at the Regulatory Institutions Network (RegNet) at the Australian National University. Holly is a founding member of Donor Families Australia; is a member of the Australian College of Critical Care Nurses Organ Donation Advisory Committee.
Holly was an organ donor coordinator and manager for the ACT Organ and Tissue Donation Agency, now known as DonateLife ACT. Holly represented the ACT on national committees reviewing organ and tissue donation and served as a member of the Advisory Committee for the National Organ Donation Collaborative.
Holly is a 2006 Churchill Fellow, which enabled her to study organ donation in the United Kingdom, Spain and the United States.
Professor Bruce Pussell trained in renal medicine in Sydney, obtaining Fellowship of the Royal Australasian College of Physicians in 1978 and then went to London where he obtained his PhD in immunology from the Royal Postgraduate Medical School at the University of London in 1982. After 40 years in the practice of kidney disease, he retired in 2014.
Professor Pussell was head of the Transplant Service at the Prince of Wales Hospital from 1998 to 2013. In 2007 he established the East Coast Renal Transplant Service that operates on the Prince of Wales Campus and incorporates the Prince of Wales, Sydney Children’s, St George, St Vincent’s and Wollongong Hospitals. He has held positions as Chairman of Medicine and Director of Nephrology at POW Hospital, Area Director of Medicine and Nephrology for the South Eastern Sydney and Illawarra Area Health Service and was a member and then Chairman of the NSW Health Transplant Advisory Committee (TAC). He holds a conjoint appointment as Professor of Medicine at the Prince of Wales Clinical School, University of NSW. Professor Pussell is a member of Australian & New Zealand, American, European and International Transplantation Societies.